|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Change in allowance for credit losses | |||||
| Loss on notes receivable settlement | |||||
| Loss on vendor settlement | |||||
| Issuance common stocks for services | |||||
| Gain on sale of building | |||||
| Loss on disposal of assets | |||||
| Amortization of right-of-use asset | |||||
| Loss on investment | |||||
| Write-down of obsolete and slow-moving inventory | |||||
| Stock-based compensation expense | |||||
| Change in contingent consideration | |||||
| Non-cash interest expense | |||||
| Loss on warrant liability extinguishment | |||||
| Impairment of Goodwill | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and vendor deposits | |||||
| Due from related party | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Contract liabilities | |||||
| Lease liability | |||||
| Cash used in operating activities, discontinued operations | |||||
| NET CASH USED IN OPERATING ACTIVITIES | |||||
| INVESTING ACTIVITIES: | |||||
| Payment for acquisition | |||||
| Proceeds from sale of Saugerties building | |||||
| Collection of note receivable | |||||
| Purchases of patent | |||||
| Purchases of property and equipment | |||||
| Cash used in investing activities, discontinued operations | |||||
| NET CASH USED IN INVESTING ACTIVITIES | |||||
| FINANCING ACTIVITIES: | |||||
| Proceeds from acquisition loan | |||||
| Principal payments on loan payable | |||||
| Proceeds from security purchase agreement | |||||
| Due to related party | |||||
| Net transfers to HCWC related to Spin-Off | |||||
| Payment for series E preferred stock redemption | |||||
| Payment of induced conversions of preferred stock | |||||
| Payment on line of credit | |||||
| Cash provided by financing activities, discontinued operations | |||||
| NET CASH PROVIDED BY FINANCING ACTIVITIES | |||||
| NET DECREASE IN CASH AND RESTRICTED CASH | |||||
| CASH AND RESTRICTED CASH — BEGINNING OF YEAR | |||||
| CASH AND RESTRICTED CASH — END OF YEAR | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |||||
| Cash paid for interest | |||||
| NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Issuance of common stock in connection with series E preferred stock conversion | |||||
| 1% stated value reduction on preferred stock redemption | |||||
| Non-cash deferred offering cost | |||||
| Issuance of promissory note in connection with acquisition | |||||
| Lease acquired | |||||
| Issuance of common stock to settle debt with related party | |||||
Loading...